European Lung Cancer Congress (ELCC) 2024

Share on: 

Research coauthored by RTI Health Solutions experts will be presented at the European Lung Cancer Congress (ELCC) 2024.

Treatment (tx) patterns and clinical outcomes in unresectable stage III epidermal growth factor receptor-mutation positive (EGFRm) non-small cell lung cancer (NSCLC) treated with chemoradiotherapy (CRT): interim analysis of a global real-world (RW) study. Neal J, Lee JB, Ahn MJ, Ariyasu R, Nash C, Smith D, Nagar S, Jimenez M, Kahangire DA, Kim YJ, Nasirova F, Lin S. Poster 

Related Services